Insulin and type 1 diabetes: immune connections

被引:29
|
作者
Culina, Sloboda [1 ,2 ]
Brezar, Vedran [1 ,2 ]
Mallone, Roberto [1 ,2 ,3 ]
机构
[1] Hop St Vincent de Paul, INSERM, U986, DeAR Lab Avenir, F-75674 Paris 14, France
[2] Paris Descartes Univ, Fac Med, Paris, France
[3] Hop Hotel Dieu, AP HP, Serv Diabetol, Paris, France
关键词
BETA-CELL FUNCTION; ANTIBODY STANDARDIZATION PROGRAM; THYMIC EPITHELIAL-CELLS; ALTERED-PEPTIDE LIGAND; AUTOREACTIVE T-CELLS; ORAL INSULIN; NOD MICE; 1ST-DEGREE RELATIVES; GENE-EXPRESSION; DENDRITIC CELLS;
D O I
10.1530/EJE-12-0693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin is the hormone produced by pancreatic beta-cells, with a central role in carbohydrate and fat metabolism. Together with its precursors preproinsulin and proinsulin, insulin is also a key target antigen (Ag) of the autoimmune islet destruction leading to type 1 diabetes. Being recognized by both autoantibodies (aAbs) and autoreactive T cells, insulin plays a triggering role, at least in rodent models, in diabetes pathogenesis. It is expressed not only by beta-cells but also in the thymus, where it plays a major role in central tolerance mechanisms. We will summarize current knowledge concerning insulin, its role in beta-cell autoimmunity as initial target Ag, its recognition by aAbs and autoreactive T cells, and the detection of these immune responses to provide biomarkers for clinical trials employing insulin as an immune modulatory agent. European Journal of Endocrinology 168 R19-R31
引用
收藏
页码:R19 / R31
页数:13
相关论文
共 50 条
  • [31] 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
    Pearson, James A.
    McKinney, Eoin F.
    Walker, Lucy S. K.
    IMMUNOTHERAPY ADVANCES, 2021, 1 (01):
  • [32] Monitoring immunomodulation strategies in type 1 diabetes
    Krishnamurthy, Balasubramanian
    Lacorcia, Matthew
    Kay, Thomas W. H.
    Thomas, Helen E.
    Mannering, Stuart I.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Human insulin as both antigen and protector in type 1 diabetes
    Amdare, Nitin P.
    Shultz, Leonard D.
    Greiner, Dale L.
    Dilorenzo, Teresa P.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 (09)
  • [34] Insulin sensitizer prevents and ameliorates experimental type 1 diabetes
    Valitsky, Michael
    Hoffman, Amnon
    Unterman, Terry
    Bar-Tana, Jacob
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2017, 313 (06): : E672 - E680
  • [35] Insulin immunotherapy for pretype 1 diabetes
    Jacobsen, Laura M.
    Schatz, Desmond A.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2021, 28 (04) : 390 - 396
  • [36] Immune cell trafficking to the islets during type 1 diabetes
    Sandor, A. M.
    Jacobelli, J.
    Friedman, R. S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 198 (03) : 314 - 325
  • [37] Type 1 diabetes: immune pathology and novel therapeutic approaches
    Ling, Eleanor M.
    Lemos, Joana R. N.
    Hirani, Khemraj
    von Herrath, Matthias
    DIABETOLOGY INTERNATIONAL, 2024, 15 (04) : 761 - 776
  • [38] Targeted immune interventions for type 1 diabetes: not as easy as it looks!
    Rigby, Mark R.
    Ehlers, Mario R.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (04) : 271 - 278
  • [39] Regulatory mechanisms of immune tolerance in type 1 diabetes and their failures
    Kuhn, Chantal
    Besancon, Alix
    Lemoine, Sebastien
    You, Sylvaine
    Marquet, Cindy
    Candon, Sophie
    Chatenoud, Lucienne
    JOURNAL OF AUTOIMMUNITY, 2016, 71 : 69 - 77
  • [40] Progress in immune-based therapies for type 1 diabetes
    von Herrath, M.
    Peakman, M.
    Roep, B.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 172 (02) : 186 - 202